200780 — BCWorldPharm Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapNeutral

Annual cashflow statement for BCWorldPharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	5,870	3,194	3,019	59.8	2,892
Depreciation
Amortisation
Non-Cash Items	882	-543	1,008	2,313	3,586
Unusual Items
Other Non-Cash Items
Changes in Working Capital	2,914	-8,471	-9,621	-2,698	-3,010
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	13,325	-1,250	-5.08	6,883	10,938
Capital Expenditures	-22,540	-12,552	-19,887	-6,439	-2,709
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	714	188	1,121	-239	-1,055
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-21,826	-12,365	-18,766	-6,678	-3,764
Financing Cash Flow Items	6,110	19,310	3,550	5,454	12,760
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	7,771	22,921	10,799	1,073	-4,248
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-707	8,995	-7,925	1,276	2,963